首页> 外文OA文献 >Different administration routes of recombinant human endostatin combined with concurrent chemoradiotherapy might lead to different efficacy and safety profile in unresectable stage III non‐small cell lung cancer: Updated follow‐up results from two phase II trials

【2h】

Different administration routes of recombinant human endostatin combined with concurrent chemoradiotherapy might lead to different efficacy and safety profile in unresectable stage III non‐small cell lung cancer: Updated follow‐up results from two phase II trials

机译：重组人内皮素的不同给药途径与同时进行化学疗法相结合可能导致不可切除的阶段III非小细胞肺癌中的不同疗效和安全性曲线：从两期二期试验中更新了后续结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Ma Honglian; Hui Zhouguang; PENG Fang; Zhao Lujun; Li Dongming; Xu Yujin; Bao Yong; Xu Liming; Zhai Yirui; Hu Xiao; Wang Jin; Kong Yue; Wang Lvhua; Chen Ming;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Different administration routes of recombinant human endostatin combined with concurrent chemoradiotherapy might lead to different efficacy and safety profile in unresectable stage III non‐small cell lung cancer: Updated follow‐up results from two phase II trials [J] . Ma Honglian, Hui Zhouguang, PENG Fang, Thoracic cancer. . 2020,第4期

机译：重组人内皮素的不同给药途径与同时进行化学疗法相结合可能导致不可切除的阶段III非小细胞肺癌中的不同疗效和安全性曲线：从两期二期试验中更新了后续结果
2. Continuous Intravenous Pumping of Recombinant Human Endostatin Combined With Concurrent Chemoradiation Therapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer: Preliminary Data of a Prospective Multicenter Phase 1/2 Clinical Trial (NCT01733589) [J] . Hui Z., Ma H., Wu R., International Journal of Radiation Oncology, Biology, Physics . 2014,第5Suppla期

机译：不可切除的III期非小细胞肺癌患者持续静脉注射重组人内皮抑素并同时进行化学放疗：一项预期的多中心1/2期临床试验的初步数据（NCT01733589）
3. Phase II trial of recombinant human endostatin in combination with concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer [J] . Bao Yong, Peng Fang, Zhou Qi-Chao, Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology . 2015,第2期

机译：重组人内皮抑素联合同步放化疗治疗III期非小细胞肺癌的II期试验
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. The effectiveness of chemoradiation for stage III non-small-cell lung cancer patients at the Kingston Regional Cancer Center (Ontario). [D] . Sinclair, Suzanne Marie. 2003

机译：金斯敦地区癌症中心（安大略省）对III期非小细胞肺癌患者进行化学放射治疗的有效性。
6. Different administration routes of recombinant human endostatin combined with concurrent chemoradiotherapy might lead to different efficacy and safety profile in unresectable stage III non‐small cell lung cancer: Updated follow‐up results from two phase II trials [O] . Ma Honglian, Hui Zhouguang, PENG Fang, 2020

机译：重组人内皮抑素联合同步放化疗的不同给药途径可能导致不可切除的III期非小细胞肺癌的疗效和安全性不同：两项II期临床试验的最新随访结果
7. A Phase I Trial of the HIV Protease Inhibitor Nelfinavir with Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer: A Report of Toxicities and Clinical Response [O] . Rengan Ramesh, Mick Rosemarie, Pryma Daniel, 2012

机译：HIV蛋白酶抑制剂Nelfinavir并发放化疗治疗不可切除的IIIA / IIIB期非小细胞肺癌的I期试验：毒性和临床反应报告

Different administration routes of recombinant human endostatin combined with concurrent chemoradiotherapy might lead to different efficacy and safety profile in unresectable stage III non‐small cell lung cancer: Updated follow‐up results from two phase II trials

著录项

相似文献

相关主题

期刊订阅